Alphadyne Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19M Sell
52,500
-60,300
-53% -$20.6M 0.18% 99
2026
Q1
$39.7M Buy
112,800
+111,200
+6,950% +$39.6M 0.69% 27
2025
Q4
$524K Buy
+1,600
New +$508K 0.01% 577
2025
Q3
Sell
-800
Closed -$223K 303
2025
Q2
$223K Buy
+800
New +$227K 0.04% 136
2023
Q4
Sell
-22,200
Closed -$5.97M 43
2023
Q3
$5.97M Buy
+22,200
New +$5.54M 0.45% 53

Other funds holding AMGN

Alphadyne Asset Management's AMGN Position: Q2 2026 in Review

Alphadyne Asset Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 15,097 shares — an estimated $5.17M sold.

Alphadyne Asset Management first reported a position in AMGN in Q3 2023 and held it in 3 quarters. The position peaked at $5.31M in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Alphadyne Asset Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Alphadyne Asset Management sold 15,097 Amgen shares in Q2 2026, an estimated $5.17M.
  • Alphadyne Asset Management first reported a position in Amgen in Q3 2023 and held it in 3 quarters.
  • Alphadyne Asset Management's Amgen position peaked at $5.31M in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.